OrbiMed
OrbiMed is a global investment firm specializing in the healthcare sector. With over 25 years of experience, OrbiMed invests in companies across the healthcare industry, including biopharmaceuticals, medical devices, diagnostics, and healthcare services. The firm manages approximately $18 billion in assets and operates from multiple global locations, aiming to drive innovation and improve patient outcomes through strategic investments.
What We Do
OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build portfolio companies into market leaders globally.
OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital and can monetize royalty streams, offering valuable financing solutions to intellectual property owners.
OrbiMed manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts, investing across all types of publicly-traded healthcare companies worldwide.
Investment Range
Portfolio
Developing a proprietary RNA targeting platform for life-saving therapeutics.
#Biopharmaceuticals
Applies precision medicine to develop life-changing medicines for rare diseases and cancer.
#Biopharmaceuticals
Focuses on targeted oncology drug discovery using mechanistic biology and medicinal chemistry.
#Biopharmaceuticals
Key People
Managing Partner
General Partner
General Partner
Venture Partner
Venture Advisor